Scenario A large pharmaceutical company maintains data related to its research and development in several proprietary, structured databases. The information contained in the database is regularly updated with results of new trials. The company receives a subpoena from a regulatory agency requesting documents related to clinical trials that were completed in advance of releasing a new product. To fully respond to the subpoena, information maintained in those databases must be collected, reviewed and potentially produced.
Stay up-to-date on our perspectivesSubscribe to Email